UPS decided cold boxes matter now. Forty-eight million dollars worth of cold boxes. Healthcare logistics is booming, which means someone finally noticed that medicine melts when you leave it in a truck in Phoenix.
Temperature-controlled facilities. That's what we're calling refrigerators now. UPS will store vaccines and biologics and whatever else needs to not cook itself to death between the factory and your grandma's arm. The company made this announcement exclusively to CNBC, because nothing says critical infrastructure investment like a cable news exclusive.
Retail traders will read this headline and think they've uncovered the next logistics play. They'll buy calls on Monday. They'll tell their friends about the healthcare boom. They'll forget that UPS has been delivering medical supplies since before their fathers discovered Robinhood. But sure, this changes everything.
The healthcare logistics market is expanding. Demand for cold chain services is up. These are facts a person could have guessed by simply living through the last three years. UPS is responding by building warehouses with thermostats. Revolutionary stuff.
Forty-eight million sounds big until you remember UPS generates over a hundred billion in revenue. This is a rounding error with a press release. The company will install some cooling units, hire some people who know how to read a thermometer, and continue doing exactly what it's been doing. Your chart will not care.
Some analyst at a mid-tier firm is already updating his price target based on this news. He'll add two dollars to his twelve-month projection. He'll cite margin expansion in high-value verticals. He'll be wrong for reasons that have nothing to do with cold storage.
The stock will move based on interest rates and fuel costs and whether the CEO sneezes during the earnings call, not because UPS remembered that insulin shouldn't bake in the sun.
Photo by Salvador Rios on Unsplash
Leave a Comment